Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $52.00 by Analysts at The Goldman Sachs Group
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) had its price objective cut by The Goldman Sachs Group from $60.00 to $52.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s target price would indicate a potential upside of […]
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) had its price objective cut by The Goldman Sachs Group from $60.00 to $52.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s target price would indicate a potential upside of […]
